Ex-4 significantly inhibits the metastatic potential of ovarian cancer cells by downregulating the expression of endothelial adhesion molecules and reducing the protein levels of vascular endothelial growth factor (VEGF) [78]. This evidence concerns the gene VEGFA and ovarian carcinoma.